Prosecution Insights
Last updated: May 29, 2026

Examiner: HENLEY III, RAYMOND J

Tech Center 1600 • Art Units: 1614 1629 1652

This examiner grants 84% of resolved cases

Performance Statistics

83.5%
Allow Rate
+23.5% vs TC avg
1,282
Total Applications
+2.1%
Interview Lift
693
Avg Prosecution Days
Based on 1249 resolved cases, 2023–2026

Rejection Statute Breakdown

2.0%
§101 Eligibility
5.5%
§102 Novelty
24.1%
§103 Obviousness
25.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17790594 METHODS OF USING ANDROGRAPHOLIDE, ORIDONIN AND ISOLIQUIRITIGENIN AND DERIVATIVES THEREOF Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
19315454 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19303300 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19267447 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19260035 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19245208 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19215242 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Final Rejection Veradermics, Incorporated
19094703 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
18419878 VIRAL PROPHYLAXIS TREATMENT METHODS AND PRE-EXPOSURE PROPHYLAXIS KITS Non-Final OA ELIAN LLC
18495512 FIBROTIC TREATMENT Final Rejection Monash University
18549916 NASAL COMPOSITIONS COMPRISING ALCAFTADINE Non-Final OA ALKEM LABORATORIES LIMITED
18227808 PPARAXANTHINE-BASED COMPOSITIONS FOR INHIBITING INFLAMMATION, IMPROVING JOINT HEALTH, AND ENHANCING IMMUNE FUNCTION Non-Final OA PX ING, LLC
18227719 BIOSYNTHESIS OF SUBSTITUTED COMPOUNDS AND CANNABINOIDS Non-Final OA Invizyne Technologies, Inc.
17555763 Delivery System For Ayahuasca-Like Substances Non-Final OA Monster Color Carnival LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month